Rheumatology News, Info, Symptoms

* Rheumatology101 SEARCH *

*Filter: "Rheumatoid"

ChatGPT: Chat, Work, Create & Code with AI
Use ChatGPT to answer questions, write, create images, complete work, and code—all in one place. Get started for free or download the app.

ChatGPT
Use ChatGPT to answer questions, write, create images, complete work, and code—all in one place. Get started for free or download the app.

OpenAI | Research & Deployment
We believe our research will eventually lead to artificial general intelligence, a system that can solve human-level problems.

Introducing ChatGPT - OpenAI
We’ve trained a model called ChatGPT which interacts in a conversational way. The dialogue format makes it possible for ChatGPT to answer followup questions, admit its mistakes, challenge incorrect premises, and reject inappropriate requests.

ChatGPT - Wikipedia
ChatGPT is a generative AI chatbot developed by OpenAI. Originally released on November 30, 2022, the product uses large language models —specifically generative pre-trained transformers (GPTs)—to generate text, speech, and images in response to user prompts.

Get started | ChatGPT
Log in or sign up to ChatGPT

ChatGPT
Usa ChatGPT para responder preguntas, escribir, crear imágenes, completar tareas y programar, todo en un solo lugar. Empieza gratis o descarga la aplicación.

ChatGPT
Usa ChatGPT para responder preguntas, escribir, crear imágenes, completar tareas y programar, todo en un solo lugar. Empieza gratis o descarga la aplicación.

Download ChatGPT
Download the ChatGPT app for Windows, Mac, iPhone, and Android. Access ChatGPT Work and Codex, use voice conversations, create images, and connect your files and apps.

ChatGPT Plan | Free
Chat with your files and images Upload a document or image, then ask questions about it. ChatGPT can read, summarize, or explain what it sees.

* Rheumatology101 LATEST NEWS *

*Filter: "Rheumatoid"

Catching the early signs of juvenile idiopathic arthritis  UT Physicians
Discordance between patient and physician global assessments amongst South Africans with rheumatoid arthritis  frontiersin.org
Rosnilimab Emerges as a Potential Advance in Rheumatoid Arthritis as Physicians Look to the Next Wave of Pipeline Innovation  Yahoo Finance
Shortage of critical specialty doctor impacts patients nationwide  NBC News
Dear Doctor: Allergic to RA medications? Biologicals might be an option  OregonLive.com
2026 Top Doctor Mark Freijat, M.D. Rheumatology  phoenixmag.com
Switching Rheumatologists? Here’s How to Navigate  HealthCentral
What Doctors Want You to Know About Arthritis in the Hands  Prevention
What to Know About Methotrexate for Rheumatoid Arthritis  Everyday Health
Doctors try new approaches to treatment of autoimmune diseases  WJAR
Artificial Intelligence in Rheumatoid Arthritis Reshapes Care  European Medical Journal
Dear Doctor: Rheumatoid Arthritis meds clashing with vaccine I really need; what should I do?  Syracuse.com
This tiny neck implant is helping some arthritis patients. Here’s how it works  Austin American-Statesman
Local doctor featured on 6abc for rheumatoid arthritis treatment  Around Ambler
Squeezing more from arthritis drugs to help patients live better | Horizon Magazine  research-and-innovation.ec.europa.eu

Common Rheumatological Symptoms

Joint Pain (Arthralgia) — Persistent discomfort or soreness in one or more joints caused by inflammation, wear and tear, or underlying autoimmune responses.
Morning Stiffness — Reduced joint mobility and tightness upon waking, often lasting over 30 to 60 minutes in inflammatory conditions like rheumatoid arthritis.
Joint Swelling and Edema — Visible enlargement of affected joints resulting from fluid accumulation in the synovial membrane and inflamed surrounding tissue.
Localized Warmth and Redness — Elevated temperature and erythema skin discoloration surrounding inflamed joints due to increased blood flow from localized inflammation.
Systemic Fatigue — Overwhelming exhaustion and lack of energy caused by ongoing chronic inflammatory cytokine activity throughout the body.
Raynaud's Phenomenon — Temporary color changes in fingers or toes turning white, blue, and red in response to cold or stress due to vascular spasms.
Malar or Butterfly Rash — Red or purplish facial rash spanning across the bridge of the nose and cheeks, classically associated with systemic lupus erythematosus.

Milestones in Rheumatology History

c. 400 BC: Hippocratic Corpus Coining — Hippocrates uses the term "rheuma" to describe body humors flowing into joints, establishing the early classical concept of joint inflammation.
1592: Formal Definition of Rheumatism — French physician Guillaume de Baillou introduces the modern term "rheumatism" to distinguish systemic acute arthritis from localized gout.
1800: Clinical Description of Rheumatoid Arthritis — Augustin Jacob Landré-Beauvais publishes the first detailed clinical description separating rheumatoid arthritis from gout, calling it "asthenic gout."
1859: Naming of Rheumatoid Arthritis — Sir Alfred Baring Garrod formally coins the term "rheumatoid arthritis" to clearly differentiate the inflammatory autoimmune condition from osteoarthritis and gout.
1940: Discovery of the Rheumatoid Factor — Erik Waaler discovers autoantibodies in the blood of patients with rheumatoid arthritis, laying the groundwork for serological autoimmune diagnostics.
1948: Introduction of Corticosteroid Therapy — Philip Hench and Edward Kendall demonstrate the dramatic anti-inflammatory effects of Compound E (cortisone) in treating rheumatoid arthritis, earning the Nobel Prize.
1998: Emergence of Biologic DMARDs — The FDA approves the first TNF-alpha inhibitors, ushering in the modern era of targeted biologic therapies for autoimmune rheumatic diseases.

Current Trends in Rheumatology Research

Chimeric Antigen Receptor (CAR) T-Cell Reset Therapy — Investigating engineered cellular therapies to achieve drug-free, durable clinical remissions by completely depleting pathogenic autoantibodies in severe refractory lupus and systemic sclerosis.
Selective TYK2 and Oral JAK Pathway Inhibition — Developing highly targeted, small-molecule oral inhibitors like deucravacitinib that disrupt specific cytokine signaling pathways while minimizing broader off-target side effects.
Targeted Pathogenic T-Cell and B-Cell Depletion — Evaluating novel biologics, such as rosnilimab and ianalumab, designed to selectively deplete overactive immune cell subpopulations involved in rheumatoid arthritis and Sjögren's disease.
Biomarker-Driven Precision Medicine — Utilizing pharmacogenomics and molecular biomarkers to predict individualized therapeutic responses and match systemic autoimmune conditions to specific biological mechanisms.
Subclinical Interception and Disease Prevention — Identifying seropositive individuals early using high-risk autoantibody profiles to initiate preventive targeted therapies before irreversible joint damage occurs.
Artificial Intelligence and Predictive Disease Modeling — Deploying machine learning algorithms across electronic health records and imaging modalities to forecast inflammatory flares and refine diagnostic accuracy.